4/A

PRIMARY DOCUMENT

Company: Sarepta Therapeutics, Inc.
Filed: January 4, 2011
Period of Report: January 3, 2011
Accession Number: 0000873303-11-000004

View Document ↗ View on SEC.gov ↗